Early day motion 62

GROUP B STREPTOCOCCUS

Main content

Total number of signatures: 46

Amess, David Anderson, David Beith, Alan Bottomley, Peter
Brady, Graham Campbell, Gregory Campbell, Menzies Campbell, Ronnie
Caton, Martin Crausby, David Crockart, Mike Dobbin, Jim
Dodds, Nigel Donaldson, Jeffrey Durkan, Mark Esterson, Bill
Farron, Tim Flynn, Paul George, Andrew Glindon, Mary
Hancock, Mike Hemming, John Hermon, Lady Heyes, David
Hopkins, Kelvin Howarth, George Lavery, Ian Llwyd, Elfyn
Long, Naomi McCrea, Dr William McDonnell, Alasdair McDonnell, John
Morris, Grahame M Osborne, Sandra Owen, Albert Pugh, John
Ritchie, Margaret Robertson, John Rotheram, Steve Ruddock, Joan
Shannon, Jim Sheridan, Jim Simpson, David Soames, Nicholas
Walley, Joan Wilson, Sammy

That this House is concerned that the reported incidence of Group B streptococcus (GBS) infection in newborn babies in England, Wales and Northern Ireland increased by 32 per cent between 2003 and 2010; recognises that GBS is the most common cause of life-threatening infection in newborn babies in the UK; notes that without preventative action one in 1,000 newborn babies per year will develop GBS infection, of whom approximately 75 will die and 40 will survive with long-term problems; welcomes the current review of the benefits of a national screening programme being undertaken by the UK National Screening Committee; and further notes that where screening programmes have been introduced, including in the United States, Spain, Australia and France, reported cases of GBS infection in newborn babies have fallen by 86 per cent, 86 per cent, 82 per cent and 71 per cent respectively.